International Technidyne Corporation Says CMS Decision to Expand Coverage for INR Self-Testing Will Increase the Market Opportunity for its ProTime(R) Microcoagulation System
EDISON, N.J.--(BUSINESS WIRE)--International Technidyne Corporation (ITC), a subsidiary of Thoratec Corporation (NASDAQ:THOR), today said the recent decision by the Centers for Medicare & Medicaid Services (CMS) to expand reimbursement for home prothrombin time monitoring will increase the market opportunity for its ProTime offering.